Breaking News on Supplements & Nutrition - EuropeUS edition

On your radar > Omega-3

Omega-3

Whether fish-derived or vegetarian, omega-3 has become a household term. Supplement sales continue to grow, and more and more foods are being fortified with the healthy fatty acids. But getting omega-3 foods into the mainstream remains a challenge.

Nutricia wins follow-on milk TV ad battle over ‘2x’ nutrient claims

Infant and medical food specialist Nutricia has had a UK TV campaign claiming toddlers needed twice the nutrients of adults backed by the watchdog there.

Cholesterol lowering bread: Researcher reveals method using whole grain oats

A new way to produce heart healthy bread from whole grain oats could help industry create a new area of functional bread products backed by EU health claims, according to...

Omega-3 may delay metabolic malady and block mental declines: Study

Supplementation with omega-3 polyunsaturated fatty acids (PUFA) could postpone the onset of metabolic disorders and associated declines in cognitive functioning, according to new research.

There’s something fishy about this milk… not anymore US scientists claim

US researchers claim they have proved it possible to incorporate omega-3 fatty acid-rich fish oil into milk and dairy-based beverages in sufficient amounts to promote health without destroying taste or smell....

Krill wars

Neptune and Aker facing off in court yet again

Australia is the site of the latest battle between Neptune and Aker Biomarine. In addition to patent strife between the two krill majors in American courts, Canadian Neptune has now...

‘Evidence is strong’ for omega-3’s heart health benefits: Linus Pauling review

The evidence supporting the heart health benefits of omega-3 fatty acids is strong, despite ‘less conclusive’ recent studies, says a new review from the Linus Pauling Institute at Oregon State...

Hot New Beverage Concepts for 2013: Episode Two

Adomas Pranevicius, CEO of MyDrink Beverages, gives BeverageDaily.com readers the further lowdown on new non-alcoholic drinks concepts that could set the market alight in 2013.

Equateq, Cognis and Pronova: “Each are complementary”, says BASF

BASF’s ever-expanding nutrition unit says its €644m bid last week bid for Norwegian omega-3 firm, Pronova Biopharma, is as important for its food supplements business as its pharmaceutical operations.

Omega-3 backed for postpartum depression

Increasing the levels of omega-3 fatty acids could help to battle postpartum depression, according to a new review.

Rimfrost taps Aker's Australian krill patents

Olympic Seafood-owned krill subsidiary Rimfrost has negotiated a long-term, non-exclusive licencing agreement with fellow Norwegian firm Aker BioMarine to secure access to the krill major's patent portfolio in Australia.

Reckitt Benckiser-Schiff: Another giant jumps into nutra space

UK-based consumer goods firm Reckitt Benckiser told NutraIngredients today, “nutrition had been on its radar for awhile”, as it plunged $1.4bn (€1.09bn) to outbid German pharma firm Bayer for the US’s second...

Fluxome finds a last-minute buyer: But is it resveratrol or omega-3 to be sold?

Swiss biotech firm Evolva has agreed to buy undisclosed assets from Fluxome, as it leaves its pure pharma research past in the dust and throws the embattled Danish supplier a...

BASF bids $823m for Pronova

BASF bids $823m for GSK omega-3 supplier Pronova Biopharma

BASF has made a bid for Pronova Biopharma ASA, underlining its intention to become the dominant player in the pharmaceutical grade omega-3 API market.  

Rise of healthy/functional foods behind UK supplements slip

The UK food supplements market has shed 3 million users since 2008, a result of the economic slowdown and more savvy consumers choosing functional and healthier foods, according to Mintel.

DSM buys Fortitech for €495m; “We are done for awhile”

Rampant nutrition business acquirer, Royal DSM, has splashed the cash for the ninth time in two years – this time to the tune of €495m ($634m) on US-based multinational nutrient...

News in brief

Bioriginal to distribute Norwegian krill

Canadian lipid specialist Bioriginal has inked a deal with Olympic Seafood to distribute the Norwegian firm’s krill offerings.

News in brief

Aker secures four krill ‘innovation patents’ in Australia

Aker BioMarine has announced that its claims covering krill oil compositions on sale in Australia have been awarded “innovation patents”. 

Q3 wrap: Nutrition stars for DSM and Naturex

Royal DSM saw Q3 sales slip 7% to €2.3bn across all divisions with polymer intermediates performing worst, but as has been the case in recent quarters, the Dutch firm’s nutrition...

"The present results do not change the totality of the evidence [...] Consumers should continue to eat fish, as well as take their omega-3 products for heart health.” Dr Harry Rice, GOED

Meta-analysis supports fish, questions supplements, for stroke risk

Regular consumption of fish may reduce the risk of coronary heart disease and stroke, but the benefits of fish oil supplements may be minimal, says a new analysis by researchers...

Bayer “absolutely open” to further acquisitions after $1.2bn Schiff shop

The consumer arm of German pharma giant Bayer Healthcare is to pay $1.2bn (€920m) for US food supplements company Schiff Nutrition International, a move that will make it one of...

DHA omega-3 may lower anxiety risk

Increased intakes of the omega-3 DHA (docosahexaenoic acid) are associated with a reduced risk of anxiety, a study from Australia has reported for the first time.

Omega-3 may boost working memory in healthy young adults: Study

Increasing intakes of omega-3 may improve the working memory of young adults who are at the peak of their cognitive abilities, according to new data.

Asian krill boom drives krill joint venture

Australian, Japanese, South Korean, Taiwanese and other Asian consumers are driving rising demand in omega-3 source krill to levels that have prompted Norwegian krill supplier, Rimfrost, to ink a production-boosting...

BASF wants a share of pharma omega-3 market

BASF wants a share of the $1.5bn global market for drug grade omega-3 and expects the plant it is building to start shipping product early next year.